467 related articles for article (PubMed ID: 8707283)
1. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
[TBL] [Abstract][Full Text] [Related]
2. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
Abayli B; Canataroğlu A; Akkiz H
Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
[TBL] [Abstract][Full Text] [Related]
3. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
[TBL] [Abstract][Full Text] [Related]
4. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.
El-Kady IM; Lotfy M; Badra G; El-Masry S; Waked I
Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127
[TBL] [Abstract][Full Text] [Related]
6. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
8. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines.
Napoli J; Bishop GA; McGuinness PH; Painter DM; McCaughan GW
Hepatology; 1996 Oct; 24(4):759-65. PubMed ID: 8855173
[TBL] [Abstract][Full Text] [Related]
9. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
10. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
[TBL] [Abstract][Full Text] [Related]
11. Determination of serum cytokines in individuals with HCV infection.
Fan X; Liu W; Li C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):145-7. PubMed ID: 11503046
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
13. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
[TBL] [Abstract][Full Text] [Related]
14. Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance.
Casanovas-Taltavull T; Ercilla MG; Gonzalez CP; Gil E; Viñas O; Cañas C; Casanova A; Figueras J; Serrano T; Casais LA
Liver Transpl; 2004 May; 10(5):584-94. PubMed ID: 15108249
[TBL] [Abstract][Full Text] [Related]
15. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.
Nelson DR; Tu Z; Soldevila-Pico C; Abdelmalek M; Zhu H; Xu YL; Cabrera R; Liu C; Davis GL
Hepatology; 2003 Oct; 38(4):859-68. PubMed ID: 14512873
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
18. [Predictor of effect of interferon-alpha on patients with hepatitis B: Th1/Th2 type cytokines].
Xing T; Zhang L; Lu Q
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):268-70. PubMed ID: 11798769
[TBL] [Abstract][Full Text] [Related]
19. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.
Martín J; de Sequera P; Quiroga JA; Rico M; Fernández M; Arocena C; Caramelo C; Carreño V
Cytokine; 2000 Aug; 12(8):1248-52. PubMed ID: 10930306
[TBL] [Abstract][Full Text] [Related]
20. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.
Xing T; Zhang L; Lu Q; Hou J; Feng X; Luo K
Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]